Medtronic, Inc.

710 Medtronic Pkwy
Minneapolis, MN 55432-5604
USA
Phone:
763-514-4000
Fax:
763-514-4879
www.medtronic.com

Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.

Related Content

Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 programmers used to download software from the Medtronic software distribution network (SDN) . This update is a voluntary recall correction by the manufacturer to address the safety risk caused by the cybersecurity vulnerability.

Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 implantable EP device programmers.

Feature | Cybersecurity | October 17, 2018
FDA Says Medtronic is Updating Cybersecurity Vulnerabilities of its Implantable Cardiac Device Programmers
October 17, 2018 — The U.S.
read more
Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
News | Stents Drug Eluting | October 01, 2018
Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-c
read more
Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy
News | Drug-Eluting Balloons | September 24, 2018
Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy
 New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego,...
read more
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
read more
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
read more
Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic Begins Pilot Study of Investigational Extravascular ICD System
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
read more
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
read more
FDA Approves 200, 250 Millimeter In.Pact Admiral Drug Coated Balloons
Technology | Drug-Eluting Balloons | June 15, 2018
FDA Approves 200, 250 Millimeter In.Pact Admiral Drug Coated Balloons
Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of the In.Pact...
read more
The Medtronic HeartWare Ventricular Assist Devices (HVAD) has a Class I FDA recall.
Feature | Ventricular Assist Devices (VAD) | June 04, 2018
Medtronic HeartWare HVAD System Recalled Due to Unintended Disconnection of Power Source
June 4, 2018 — The U.S.
read more
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing strong early...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init